Federal award (PURCHASE ORDER, fiscal year 2023)
Recipient: NANOVIEW BIOSCIENCES, INC.
Awarding agency: Department of Health and Human Services / Food and Drug Administration
Funding agency: Department of Health and Human Services / Food and Drug Administration
Period of performance: 2021-09-07 to 2022-10-07
Current total value of award: $140460.04
Description: NANOVIEW BIOSCIENCES EXOVIEW R100- THE PURPOSE OF THIS MODIFICATION IS TO DE-OBLIGATE FUNDS AND CLOSE OUT THE CONTRACT.